Results: There were significant differences in the serum and urinary levels of KIM-1 and β2MG between the SLE group and the control group, as well as among subgroups with different manifestations (renal, cutaneous, and hematological). This evidence concerns the gene HAVCR1 and systemic lupus erythematosus.